{
    "nct_id": "NCT03987854",
    "official_title": "The University of Michigan PCOS Intervention Using Nutritional Ketosis",
    "inclusion_criteria": "* We will include women in one PCOS subtype, those having these two symptoms:\n\n  * Hyperandrogenism - (a) If not on current birth control: hyperandrogenism defined as current elevated total testosterone >= 50 ng/dL or free androgen index > 1.5 (ratio of testosterone/SHBG x 100) or severe acne or hirsutism (b) if on current birth control: history from the past 10 years of hyperandrogenism defined as past elevated total testosterone >= 50 ng/dL or free androgen index > 1.5 (ratio of testosterone/SHBG x 100) or severe acne or hirsutism\n  * oligomenorrhea-anovulation defined as spontaneous intermenstrual periods of ≥ 45 days or a total of ≤ 8 menses per year.\n\nParticipants must also be:\n\n* overweight or obese (BMI 25-50)\n* be 21-40 years old\n* have regular access to the internet\n* be able to engage in light physical activity\n* willing and able to follow the assigned intervention.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 21 Years\nMust have maximum age of 40 Years",
    "exclusion_criteria": "* a non-English speaker\n* inability to complete baseline measurements\n* a substance abuse, mental health, or medical condition that would interfere with participation (such as current chemotherapy)\n* pregnant or planning to get pregnant in the next 6 months\n* type 1 or type 2 diabetes\n* baseline aspartate aminotransferase (AST) or alanine aminotransferase (ALT) > 2 times normal\n* baseline renal disease defined as BUN > 30 mg/dL or serum creatinine >1.4 mg/dL\n* baseline uncorrected thyroid disease (TSH <0.45 mIU/ML or >4.5 mIU/ML)\n* breastfeeding or less than 6 months post-partum\n* planned or history of weight loss surgery\n* vegan or vegetarian\n* currently enrolled in a weight loss program or other investigative study that might conflict with this research\n* taking medications known to cause weight gain or loss\n* taking hypoglycemic medications other than metformin or medications known to affect metabolism\n* or patients with other etiologies of anovulation and hyperandrogenism, e.g., Cushing's disease, thyroid dysfunction, elevated prolactin levels, signs of congenital adrenal hyperplasia, organic intra cranial lesion such as a pituitary tumor, or suspected adrenal or ovarian tumor secreting androgens.",
    "miscellaneous_criteria": ""
}